Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Dec;26(12):3897-3913.
doi: 10.1007/s10461-022-03717-2. Epub 2022 Jun 7.

Randomized Controlled Trial of a Remote Coaching mHealth Adherence Intervention in Youth Living with HIV

Affiliations
Randomized Controlled Trial

Randomized Controlled Trial of a Remote Coaching mHealth Adherence Intervention in Youth Living with HIV

K Rivet Amico et al. AIDS Behav. 2022 Dec.

Abstract

Youth living with HIV (YLWH) in the US have low rates of viral suppression (VS). In a prospective randomized clinical trial (ATN152) that enrolled 89 YLWH on antiretroviral therapy (ART) with detectable viral load, we evaluated a 12 week triggered escalating real-time adherence (TERA) intervention with remote coaching, electronic dose monitoring (EDM), and outreach for missed/delayed doses compared to standard of care (SOC). Median [Q1, Q3] percent days with EDM opening was higher in TERA (72% (47%, 89%)) versus SOC (41% (21%, 59%); p < 0.001) and incidence of numbers of 7 day gaps between openings were lower (TERA to SOC ratio: 0.40; 95% CI 0.30, 0.53; p < 0.001). There were no differences in VS at week 12 (TERA 35%; 95% CI 21%, 51% versus SOC 36%; 95% CI 22%, 51%; p > 0.99) or later time-points. The intervention improved adherence but not VS in heavily ART-experienced YLWH. Remote coaching more closely tailored to the unique dosing patterns and duration of need for youth struggling to reach VS warrants further investigation.

Keywords: Coaching; EDM; Intervention; Viral suppression; YLWH; Youth; mHealth.

PubMed Disclaimer

Conflict of interest statement

The authors report no financial interests and no conflicts of interest relevant to the subject matter discussed in this manuscript.

Figures

Fig. 1
Fig. 1
Consort diagram. Grayed text represents post COVID-19 pandemic related pause in data collection- not used in primary analyses
Fig. 2
Fig. 2
Viral Suppression and Viral Load Outcomes
Fig. 3
Fig. 3
Median percent days EDM device opened by week
Fig. 4
Fig. 4
Scatterplot (LOESS line) of log10 HIV-1 RNA vs. GAP IR and percent days opened (PCT12) by 12-week period

References

    1. Harris NS, Johnson AS, Huang YA, Kern D, Fulton P, Smith DK, et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis - United States, 2013–2018. MMWR Morb Mortal Wkly Rep. 2019;68(48):1117–1123. doi: 10.15585/mmwr.mm6848e1. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. HIV surveillance report, 2018 (Updated); vol. 31. Published May 2020.
    1. Kapogiannis BG, Koenig LJ, Xu J, Mayer KH, Loeb J, Greenberg L, et al. The HIV continuum of care for adolescents and young adults attending 13 urban US HIV care centers of the NICHD-ATN-CDC-HRSA SMILE collaborative. J Acquir Immune Defic Syndr. 2020;84(1):92–100. doi: 10.1097/QAI.0000000000002308. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. HIV and Youth. 2020. https://www.cdc.gov/hiv/group/age/youth/incidence.html Accessed March 4 2022.
    1. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data: United States and 6 dependent areas, 2018. HIV Surveillance Report 2020; 25(No. 2). https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveil... Accessed March 4 2022.

Publication types

Substances